From January 1, 2022 to March 23, 2022, the company has repurchased 240,000 shares, representing 0.84% for ¥255.53 million. With this, the company has completed the repurchase of 300,000 shares, representing 1.06% for ¥316.48 million under the buyback announced on July 12, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,111 JPY | +0.43% | -6.88% | +18.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.33% | 385M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- 4886 Stock
- News ASKA Pharmaceutical Holdings Co.,Ltd.
- Tranche Update on ASKA Pharmaceutical Holdings Co.,Ltd.'s Equity Buyback Plan announced on July 12, 2021.